» Articles » PMID: 14734823

Generation and Production of Engineered Antibodies

Overview
Journal Mol Biotechnol
Publisher Springer
Date 2004 Jan 22
PMID 14734823
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Various forms of recombinant monoclonal antibodies are being used increasingly, mainly for therapeutic purposes. This review specifically focuses on what is now called antibody engineering, and discusses the generation of chimeric, humanized, and fully human recombinant antibodies, immunoglobulin fragments, and artificial antigen-binding molecules. Since the production of recombinant antibodies is a limiting factor in their availability, and a shortage is expected in the future, different expression systems for recombinant antibodies and transgenic organisms as bioreactors are also discussed, along with their advantages and drawbacks.

Citing Articles

Directing evolution of novel ligands by mRNA display.

Kamalinia G, Grindel B, Takahashi T, Millward S, Roberts R Chem Soc Rev. 2021; 50(16):9055-9103.

PMID: 34165126 PMC: 8725378. DOI: 10.1039/d1cs00160d.


The reduced form of the antibody CH2 domain.

Xi Z, Liu X, Lin R, Persons J, Ilina T, Li W Protein Sci. 2021; 30(9):1895-1903.

PMID: 34107549 PMC: 8376410. DOI: 10.1002/pro.4142.


Cloning and expression of an anti-LDL(-) single-chain variable fragment, and its inhibitory effect on experimental atherosclerosis.

Kazuma S, Cavalcante M, Telles A, Maranhao A, Abdalla D MAbs. 2013; 5(5):763-75.

PMID: 23924793 PMC: 3851228. DOI: 10.4161/mabs.25859.


Aggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.

Hasegawa H Int J Cell Biol. 2013; 2013:604867.

PMID: 23533417 PMC: 3603282. DOI: 10.1155/2013/604867.


Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay.

Kim H, McCoy M, Majkova Z, Dechant J, Gee S, Tabares-da Rosa S Anal Chem. 2011; 84(2):1165-71.

PMID: 22148739 PMC: 3264785. DOI: 10.1021/ac2030255.


References
1.
Tan P, Mitchell D, Buss T, Holmes M, Anasetti C, Foote J . "Superhumanized" antibodies: reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: application to an anti-CD28. J Immunol. 2002; 169(2):1119-25. DOI: 10.4049/jimmunol.169.2.1119. View

2.
McCafferty J, Glover D . Engineering therapeutic proteins. Curr Opin Struct Biol. 2000; 10(4):417-20. DOI: 10.1016/s0959-440x(00)00108-1. View

3.
MCCONNELL S, Hoess R . Tendamistat as a scaffold for conformationally constrained phage peptide libraries. J Mol Biol. 1995; 250(4):460-70. DOI: 10.1006/jmbi.1995.0390. View

4.
Glockshuber R, Malia M, Pfitzinger I, Pluckthun A . A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry. 1990; 29(6):1362-7. DOI: 10.1021/bi00458a002. View

5.
Pollock D, Kutzko J, Williams J, Echelard Y, Meade H . Transgenic milk as a method for the production of recombinant antibodies. J Immunol Methods. 2000; 231(1-2):147-57. PMC: 7125573. DOI: 10.1016/s0022-1759(99)00151-9. View